We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tt Electronics Plc | LSE:TTG | London | Ordinary Share | GB0008711763 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -0.29% | 173.50 | 172.00 | 173.50 | 174.50 | 171.00 | 173.00 | 124,194 | 13:47:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Components, Nec | 613.9M | -11.8M | -0.0670 | -25.67 | 302.72M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/1/2021 14:40 | Thanks...happy to be corrected on that then. The whole episode came across as rather comical. | meijiman | |
11/1/2021 11:23 | The problem was more to do with the boss of I-Abra comments about the potential of Virolens.It was him who said the share price of TTG was chicken feed compared to what it would be when orders came in for his invention. TTG are the manufacturers. I-Abra and agents who have bought worldwide distribution rights are responsible for selling the product and authentication. TTG are not out of depth at all the have world wide manufacturing facilities. As have said the government paid initial production costs so far. Sound pretty shrewd to me | earwacks | |
07/1/2021 12:40 | Does not the 'debacle' rather suggest the ceo is a bit of a clown/naive/out of his depth? | meijiman | |
07/1/2021 11:00 | Roce is about 5 and PE of around 14. yield 2.5%. share price up to £2.15 today. Disappointingly little news on Virlolens which was being trialled for compliance back in November. Plenty of news flow on website. Probably a bit wary of media after last debacle. Virolens is a bit of a red herring. They got a £5 million government grant to develop that. Obviously it would add hugely if successful, but they continue to run a smooth operation with their more established businesses. Black Rock have been adding smallish positions recent months but up to a decent 5% holding last time I looked | earwacks | |
07/1/2021 07:39 | Peddlers, you must feel very lonely here :-) The forecasts are good but my concerns are margin and ROCE. Can you give me any insight. Cheers | johnrxx99 | |
11/12/2020 12:57 | Looks like we have buyers. Short term target for me is 240 | peddlers | |
08/12/2020 14:08 | Nicely ticking a way - down. Holding firm as next week and week after should be better for the markets. Good buying opportunity on the market weakness | peddlers | |
07/12/2020 12:06 | Nicely ticking away | peddlers | |
04/12/2020 11:55 | Still moving up. Get them before they explode to 240+ | peddlers | |
03/12/2020 11:21 | Still ticking along nicely. One for the Christmas rally for sure | peddlers | |
03/12/2020 08:28 | wondering if we will test recent highs of C. 230 by year end. | peddlers | |
02/12/2020 11:06 | Holding firm. I expect TTG to be trading above 240 in the short term. | peddlers | |
01/12/2020 15:09 | Moving back up | peddlers | |
26/11/2020 15:45 | I have added a few anyway as my holding is not that large. Wide stop. | peddlers | |
26/11/2020 15:21 | The price is sitting very close to that trend line. Analyst targets above 240 on TTG. One for the Christmas rush perhaps | peddlers | |
26/11/2020 15:17 | A few big chunky trades have just gone through, Perhaps something rumbling in the background. | peddlers | |
16/11/2020 14:38 | Possibly fully valued at this moment in time but with trials in Australia being weeks away from rollout of Iabra's 'Virolens'for which Keyoptions have already bought the distribution rights outside of Europe and America the upside is pretty huge if they get approval. Seeing as no medical personnel or laboratory are required to administer the test I would think it is pretty much a formality. Quite how they intend to convince the market that it is one of the most accurate tests might be slightly more difficult as so much of the uk press and scientific community seem absolutely beside themselves with rage that these 4 guys in Iabra have come up with such a cheap, easy, practical test.They have banded together to try and discredit the background of IABRA when the reality is that they have 10 years of experience with AI. Its quite pathetic that the uk could well shoot themselves in the foot yet again and allow Virolens to free up the free world outside of the 'developed' one while the uk who love queuing can do that till their hearts content waiting hours or days for a more expensive test result. Another possible function of Virolens in development is that the results can quickly be flagged up on smartphones. It's been badly reported and the market is not sure what to believe.TTG had £5 million of taxpayers money to develop and manufacture with exclusive rights. They have manufacturing capability all over the world, although the test batches are currently coming from their base in Hartlepool. I think its time for a bit more positivity about what the guys have achieved in 3 months | earwacks | |
15/11/2020 11:44 | Picking up on this - looks like a bit of steady improvement. Which is mildly encouraging. Based on this years numbers still looks fully valued for now though | reddevils1 | |
21/10/2020 14:35 | I would like TGG to travel back to 300 a bit more slowly this time around | peddlers | |
14/10/2020 15:11 | Some nice chunky trades going through this afternoon | peddlers | |
12/10/2020 15:29 | Yes I see Robbie Burns has bought into TT Electronics. Gives me good confidence on where the price is likely to head. Soon I hope LOL P | peddlers | |
08/10/2020 11:18 | Yes I see Robbie Burns has bought into TT Electronics. Gives me good confidence on where the price is likely to head. P | peddlers |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions